Published in J Infect Dis on October 01, 1973
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
Therapy of antimicrobial-resistant typhoid fever. Antimicrob Agents Chemother (1977) 1.09
Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol (1979) 15.15
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature (1990) 5.20
Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28
Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71
Amebiasis: epidemiologic studies in the United States, 1971-1974. Ann Intern Med (1978) 3.58
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother (1980) 3.54
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis (1970) 3.41
Current concepts in parasitology. Amebiasis. N Engl J Med (1978) 3.41
Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother (1977) 3.27
A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med (1998) 3.03
Impact in the United States of the Shiga dysentery pandemic of Central America and Mexico: a review of surveillance data through 1972. J Infect Dis (1974) 2.91
Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest (1986) 2.91
Scombroid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA (1974) 2.84
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.71
Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med (1981) 2.68
Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect Immun (1986) 2.55
Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science (1984) 2.51
Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol (1980) 2.48
Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism. J Clin Invest (1978) 2.48
Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc Natl Acad Sci U S A (1994) 2.47
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J Clin Invest (1977) 2.46
Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med (1986) 2.40
International outbreak of Salmonella Eastbourne infection traced to contaminated chocolate. Lancet (1975) 2.32
Shigella surveillance in the United States, 1975. J Infect Dis (1977) 2.31
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol (1985) 2.27
Detection of Vibrio cholerae biotype El Tor by purging. Bull World Health Organ (1966) 2.27
Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med (1998) 2.24
Crystal structure of a Flp recombinase-Holliday junction complex: assembly of an active oligomer by helix swapping. Mol Cell (2000) 2.24
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis (1990) 2.22
Turtle-associated salmonellosis. I. An estimation of the magnitude of the problem in the United States, 1970-1971. Am J Epidemiol (1972) 2.15
The phage Mu transpososome core: DNA requirements for assembly and function. EMBO J (1995) 2.14
Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest (1985) 2.09
Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) (1983) 2.06
Genetic mapping of mutations in independently isolated nontoxinogenic mutants of Vibrio cholerae. Infect Immun (1978) 1.98
Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun (1995) 1.94
A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care (2000) 1.94
Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J (1996) 1.93
Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med (2001) 1.91
A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature (1993) 1.91
Plasmid-mediated resistance to antibiotic synergism in enterococci. J Clin Invest (1978) 1.90
Food poisoning due to Vibrio parahaemolyticus. Annu Rev Med (1974) 1.85
Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ (1971) 1.84
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation. Lancet (1967) 1.83
Exotoxin activity associated with the Legionnaires disease bacterium. J Clin Microbiol (1979) 1.82
Comparison of media for direct isolation and transport of Shigellae from Fecal specimens. Appl Microbiol (1970) 1.82
Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard. Antimicrob Agents Chemother (1986) 1.77
Epidemiology of an international outbreak of Salmonella agona. Lancet (1973) 1.76
Holding media for the transport of Vibrio cholerae from field to laboratory. Am J Trop Med Hyg (1971) 1.75
Epidemiology of cholera in Italy in 1973. Lancet (1974) 1.75
An epidemic-associated episome? J Infect Dis (1972) 1.72
Aromatic substrate specificity of browning by cultures of the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.68
Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens. J Infect Dis (1985) 1.67
Physical heterogeneity of neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infect Immun (1987) 1.67
Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. J Infect Dis (1986) 1.66
Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am J Trop Med Hyg (1996) 1.64
An assessment of patient-related economic costs in an outbreak of salmonellosis. N Engl J Med (1978) 1.63
Clinical features of types A and B food-borne botulism. Ann Intern Med (1981) 1.62
Cholera in Portugal, 1974.I. Modes of transmission. Am J Epidemiol (1977) 1.62
Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. J Clin Invest (1982) 1.60
Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med (1987) 1.60
Epidemiologic assessment of the relevance of the so-called enteropathogenic serogroups of Escherichia coli in diarrhea. N Engl J Med (1977) 1.59
Underdiagnosis of Chlamydia trachomatis infection. Diagnostic limitations in patients with low-level infection. Sex Transm Dis (1992) 1.57
The role of preschool children and day-care centers in the spread of shigellosis in urban communities. J Pediatr (1974) 1.57
Reliability of disc diffusion susceptibility testing. Infect Control (1982) 1.57
Laboratory methods in cholera: isolation of Vibrio cholerae (el tor and classical) on TCBS medium in minimally equipped laboratories. Trans R Soc Trop Med Hyg (1968) 1.52
The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae. J Infect Dis (1996) 1.52
Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. J Immunol (1980) 1.52
The acid-fast stain: a specific and predictive test for mycobacterial disease. Ann Intern Med (1980) 1.51
The crystal structure of the catalytic domain of the site-specific recombination enzyme gamma delta resolvase at 2.7 A resolution. Cell (1990) 1.49
Antibiotic-induced lysis of enterococci. J Clin Invest (1981) 1.49
Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis (1983) 1.47
Isolation and characterization of hypertoxinogenic (htx) mutants of Escherichia coli KL320(pCG86). Infect Immun (1981) 1.46
Institutional salmonellosis. J Infect Dis (1973) 1.46
Chemoprophylaxis and treatment of malaria. N Engl J Med (1988) 1.45
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol (2000) 1.43
Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide. J Infect Dis (1992) 1.41
Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med (1982) 1.41
Shigellosis in custodial institutions. Am J Epidemiol (1970) 1.40
Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. J Med Chem (1998) 1.40
Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969. J Infect Dis (1970) 1.39
Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA (1983) 1.39
Evaluation of thiosulfate-citrate-bile salts-sucrose agar, a selective medium for the isolation of Vibrio cholerae and other pathogenic vibrios. J Infect Dis (1974) 1.39